Targeting Upconversion Nanoprobes for Magnetic Resonance Imaging of Early Colon Cancer

Yingying Jin,Dalong Ni,Jiawen Zhang,Fang Han,Jing Wang,Lu Gao,Hua Zhang,Yanyan Liu,Zhaowen Cui,Zhenwei Yao,Xiaoyuan Feng,Wenbo Bu
DOI: https://doi.org/10.1002/ppsc.201600393
IF: 3.467
2017-01-01
Particle & Particle Systems Characterization
Abstract:Colon cancer (CC) is one of the most common intestinal malignancies and is difficult to detect in its early stage by magnetic resonance imaging (MRI) with currently used contrast agents (CAs). The development of targeted CAs contributes to the early diagnosis of CC and thereby enables early intervention and timely therapy. Considering the outstanding performance of upconversion nanoprobes (UCNPs) in high-performance MR and fluorescence imaging, a new type of nanoprobes with considerably enhanced imaging performance is developed herein. Carcinoembryonic antigen (CEA) antibody is conjugated onto the surface of UCNPs to achieve the targeted imaging of early CC tumors, which overexpress CEA. Both toxicity tests and histological/hematological examinations demonstrate the excellent biocompatibility of these CC-targeting nanoprobes, which possess great potential for clinical application in the early diagnosis of CC.
What problem does this paper attempt to address?